当前位置:首页 - 行情中心 - 瑞康医药(002589) - 财务分析 - 资产负债表

瑞康医药

(002589)

  

流通市值:52.85亿  总市值:58.23亿
流通股本:13.66亿   总股本:15.05亿

资产负债表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
流动资产:
  货币资金4,241,083,430.775,978,903,824.794,974,693,794.994,984,097,408.83
  应收票据及应收账款4,173,053,386.474,258,026,088.154,257,604,606.894,054,265,954.98
  其中:应收票据439,795,378.74557,789,568.08424,364,396.67189,048,498.4
        应收账款3,733,258,007.733,700,236,520.073,833,240,210.223,865,217,456.58
  应收款项融资210,243,637.76211,232,834.45224,617,497.15320,964,479.04
  预付款项133,010,463.7380,337,885.9477,846,526.8548,181,086.82
  其他应收款合计944,694,951.74948,695,370.64883,518,814.04893,286,668.51
  存货692,925,487.73812,323,819.32690,051,695.51734,740,515.2
  其他流动资产48,017,977.9448,434,586.5348,582,678.8848,333,814.89
  流动资产合计10,443,029,336.1412,337,954,409.8211,156,915,614.3111,083,869,928.27
非流动资产:
  长期股权投资528,487,606.53528,487,606.53531,900,995.37531,900,995.37
  其他权益工具投资5,217,5615,217,5615,217,5615,217,561
  其他非流动金融资产209,606,198.25209,606,198.25209,606,198.25209,606,198.25
  投资性房地产677,746,256.07614,710,973.34576,070,448.84587,042,165.24
  固定资产1,723,765,788.181,812,221,015.971,902,250,056.591,925,931,126.1
  在建工程310,496,923.38302,390,856.29321,141,848.34307,338,950.73
  生产性生物资产---0
  油气资产---0
  使用权资产3,026,093.733,403,531.724,819,126.725,391,616.08
  无形资产519,546,809.84527,437,892.12428,938,269.84440,890,095.62
  开发支出22,096,622.6522,096,622.65-22,096,622.65
  商誉146,667,621.5146,667,621.5146,667,621.5146,667,621.5
  长期待摊费用29,785,913.8333,057,730.0437,228,246.9339,162,756
  递延所得税资产303,524,196.07328,828,288.85279,221,299.07286,149,319.61
  其他非流动资产405,957,089.61416,555,708.46440,359,579.08446,206,991.94
  非流动资产合计4,885,924,680.644,950,681,606.724,883,421,251.534,953,602,020.09
  资产总计15,328,954,016.7817,288,636,016.5416,040,336,865.8416,037,471,948.36
流动负债:
  短期借款5,302,030,849.497,242,802,549.96,331,689,125.446,096,685,222.16
  衍生金融负债151,259,900151,259,900-0
  应付票据及应付账款3,462,158,024.243,443,581,893.753,147,730,572.073,382,436,977.53
  其中:应付票据1,110,419,812.03924,399,792.42590,583,285.61603,382,845.17
        应付账款2,351,738,212.212,519,182,101.332,557,147,286.462,779,054,132.36
  预收款项2,775,229.355,550,458.78,325,688.0511,100,917.4
  合同负债12,423,111.6410,107,828.1112,808,196.4914,029,960.58
  应付职工薪酬18,066,070.1618,301,155.616,882,630.8219,970,326.75
  应交税费29,423,372.0715,223,942.621,843,075.4226,325,213.32
  其他应付款合计318,627,665.37247,050,440.07190,620,848.66196,957,547.21
        应付股利91,087,799.73,943,415.43,943,415.43,943,415.4
  一年内到期的非流动负债27,533,333.3462,791,655.36156,137,038.93156,137,038.93
  其他流动负债73,741,653.5662,363,546.3252,744,713.1740,700,764.56
  流动负债合计9,398,039,209.2211,259,033,370.419,938,781,889.059,944,343,968.44
非流动负债:
  长期借款425,398,360.41410,452,843.34358,447,793.97327,081,440.65
  租赁负债2,611,086.822,628,038.663,347,826.424,115,955
  递延收益4,708,662.874,714,810.24,724,8374,737,379.87
  递延所得税负债44,016,636.0845,881,580.1946,181,75148,503,310.7
  其他非流动负债---0
  非流动负债合计476,734,746.18463,677,272.39412,702,208.39384,438,086.22
  负债合计9,874,773,955.411,722,710,642.810,351,484,097.4410,328,782,054.66
所有者权益(或股东权益):
  实收资本(或股本)1,504,710,4711,504,710,4711,504,710,4711,504,710,471
  资本公积3,483,074,407.023,483,074,407.023,588,728,307.023,634,334,307.02
  减:库存股60,390,711.9560,390,711.9542,857,2000
  盈余公积167,362,440.57167,362,440.57167,362,440.57167,362,440.57
  未分配利润254,217,064.29260,246,883.5291,161,611.39242,080,438.22
  归属于母公司股东权益合计5,348,973,670.935,355,003,490.145,509,105,629.985,548,487,656.81
  少数股东权益105,206,390.45210,921,883.6179,747,138.42160,202,236.89
  股东权益合计5,454,180,061.385,565,925,373.745,688,852,768.45,708,689,893.7
  负债和股东权益合计15,328,954,016.7817,288,636,016.5416,040,336,865.8416,037,471,948.36
公告日期2025-10-302025-08-262025-04-302025-04-24
审计意见(境内)标准无保留意见
TOP↑